Juan Graham
Equibles does not estimate personal net worth.
About Juan Graham
Juan Graham was last confirmed as CFO at Perspective Therapeutics, Inc. (CATX) in a filing dated April 16, 2025. Earlier roles on record: CFO at Kyntra Bio, Inc. (KYNB) until December 15, 2024 and CFO at Kyntra Bio, Inc. (KYNB) until August 30, 2024. Perspective Therapeutics, Inc. reported in an 8-K filed January 6, 2025 that Juan Graham was appointed Chief Financial Officer and principal financial officer, effective January 6, 2025. Kyntra Bio, Inc. reported in an 8-K filed September 6, 2024 that Juan Graham was terminated as Chief Financial Officer, effective December 15, 2024. The proxy statement of Kyntra Bio, Inc. reports total compensation of $3,090,254 for Juan Graham in fiscal 2023, including a base salary of $505,000. Disclosed compensation is on record for 3 fiscal years.
“On January 2, 2025, the Board of Directors (the "Board") of Perspective Therapeutics, Inc. (the "Company") appointed Mr. Juan Graham as the Company's Chief Financial Officer and principal financial officer, in each case effective as of January 6, 2025 (the "Effective Date").”
“the Company provided notice of termination to two executive officers on August 30, 2024, each of whom will remain with the Company through a transition period: Juan Graham, Chief Financial Officer and Deyaa Adib, M.D., Chief Medical Officer.”
Affiliation history
-
Start not stated–2025-04-16
Last confirmed by a filing; no departure on record
-
Start not stated–2024-12-15
-
Start not stated–2024-08-30
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Kyntra Bio, Inc. (KYNB) | Chief Financial Officer | $505,000 | $3,090,254 |
| 2022 | Kyntra Bio, Inc. (KYNB) | Chief Financial Officer | $480,000 | $2,299,666 |
| 2021 | Kyntra Bio, Inc. (KYNB) | Chief Financial Officer | $149,546 | $2,257,957 |